Physician profile
Joseph Rodriguez
NPI 1295174969
$1,897.84
in general payments reported to CMS, 2019-2025
13 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2021: $129 · 2022: $126 · 2023: $249 · 2024: $367 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Travel and Lodging: $478 · Education: $85.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.50 |
| Travel and Lodging | $477.96 |
| Education | $85.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $477.96 | 2025 | Nanoknife |
| Janssen Biotech, INC. | $210.12 | 2021-2025 | Carvykti, Rybrevant |
| Boston Scientific Corporation | $169.56 | 2021-2022 | |
| Olympus America INC. | $162.61 | 2023-2024 | Gyrus Acmi, Itind System, Soltive |
| Pfizer INC. | $149.83 | 2023-2024 | |
| 180 Medical, INC. | $132.84 | 2023-2024 | Cure Ultra Catheter |
| Astellas Pharma Global Development | $131.55 | 2025 | Xtandi |
| Sumitomo Pharma America, INC. | $109.03 | 2023-2025 | Gemtesa |
| Abbvie INC. | $99.68 | 2023-2025 | Botox |
| Astellas Pharma US INC | $96.44 | 2019 | |
| Medtronic, INC. | $68.83 | 2023 | Interstim |
| Intuitive Surgical, INC. | $45.89 | 2025 | |
| Merck Sharp & Dohme LLC | $43.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.